Study Stopped
The trial phase of the research program was denied funding.
A Lifestyle Change Program for Managing Diabetes
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The proposed study aims to fill the gap by adapting an evidence-based intervention and conducting a pilot trial to determine the new program's estimated effect sizes on occupational resilience, A1c, and diabetes-related quality of life. Developing and adapting Lifestyle Redesign (LR) for Marshallese diabetes management is significant because it would reduce health disparities in a community that is disproportionately affected by the disease, and a large number of Marshallese (currently approximately 15,000) have resided in the northwest Arkansas region since the 1980s.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedStudy Start
First participant enrolled
August 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2025
CompletedAugust 19, 2025
August 1, 2025
Same day
June 25, 2025
August 14, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Occupational Resilience Measure (ORM 1.0)
a 20-item self-report assessment designed to evaluate occupational resilience, which is the capacity to persist in an occupation despite adversity
At time of enrollment and week 15
Diabetes-related quality of Life (RV-DQOL)
The primary objective of the RV-DQoL is to measure various aspects of quality of life affected by diabetes, including: Satisfaction: Assessing patient satisfaction with different aspects of their life, including time spent managing diabetes and receiving checkups, current treatment, knowledge about diabetes, body appearance, and overall life satisfaction. Impact: Evaluating the extent to which diabetes impacts daily life, including feelings of physical illness or pain related to treatment, embarrassment related to managing diabetes in public, and interference with family life. Worry: Assessing the degree of worry related to diabetes, such as passing out due to low blood sugar, changes in body appearance, and the potential for developing complications.
At time of enrollment and week 15
A1C lab measure
is a blood test that measures your average blood sugar (glucose) levels over the past two to three months. It works by measuring the amount of glucose attached to hemoglobin, a protein in your red blood cells responsible for carrying oxygen.
screening and week 15
Study Arms (2)
Standard of Care - Group B
NO INTERVENTIONThis group will not participate in the AHD Program. The group participants will continue their routine care but will be invited to all 6 sessions on managing a healthy diet run by the EFNEP team.
ActiveHeal Diabetes (AHD) Program - Group A
EXPERIMENTALThis group will continue routine care and participate in the AHD Program. AHD Program.
Interventions
Biweekly phone/Zoom calls to support physical activity and dietary behavior change, focused on history, experience, benefits and adaptation
Eligibility Criteria
You may qualify if:
- Marshallese Adults
- type 2 diabetes and test results (within 30 days) showing A1C greater than 6.4% or Estimated Average Glucose greater than 137 mg/dL.
- Able (and willing) to participate in exercise, diet management, and group dancing.
You may not qualify if:
- Comorbidities that limit participation in the specified activities (i.e., stepper exercises, dieting, and dancing).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2025
First Posted
July 3, 2025
Study Start
August 6, 2025
Primary Completion
August 6, 2025
Study Completion
August 6, 2025
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share